IP Library Granted Patent US 9,481,897
Granted Patent B2
US 9,481,897 · App. 14/367,160 · Granted Nov 1, 2016

Hybrid polypeptides having cellobiohydrolase activity and polynucleotides encoding same

Inventors: Ye Liu (Beijing, CN); Tarana Shaghasi (Dixon, CA)
Assignee: NOVOZYMES, INC.
C12P7/10C12N9/2402C12N9/2437C12P19/14C12Y302/01091C07K2319/00C07K2319/02Y02E50/16Y02P20/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,481,897
App. No.
14/367,160
Granted
Nov 1, 2016
Kind
B2
Abstract

The present invention provides hybrid polypeptides having cellobiohydrolase activity. The present invention also provides polynucleotides encoding the hybrid polypeptides; nucleic acid constructs, vectors and host cells comprising the polynucleotides; and processes of using the hybrid polypeptides.

Claims (34)

1. A hybrid polypeptide having cellobiohydrolase activity, comprising:

(a) a first polypeptide fragment which comprises a cellobiohydrolase catalytic domain, wherein the cellobiohydrolase catalytic domain has at least 96% sequence identity to amino acids 19 to 455 of SEQ ID NO: 2 or is a fragment of amino acids 19 to 455 of SEQ ID NO: 2 that has a cellobiohydrolase activity; and

(b) a second polypeptide fragment which comprises a carbohydrate binding domain, wherein the carbohydrate binding domain has at least 96% sequence identity to amino acids 468 to 532 of SEQ ID NO: 4 or is a fragment of amino acids 468 to 532 of SEQ ID NO: 4 that has carbohydrate binding activity;

wherein the catalytic domain is at the N-terminal end of the hybrid polypeptide and the carbohydrate binding domain is at the C-terminal end of the catalytic domain.

2. The hybrid polypeptide of claim 1 , wherein the first polypeptide fragment has at least 96% sequence identity to amino acids 19 to 455 of SEQ ID NO: 2.

3. The hybrid polypeptide of claim 1 , wherein the first polypeptide fragment has at least 97% sequence identity to amino acids 19 to 455 of SEQ ID NO: 2.

4. The hybrid polypeptide of claim 1 , wherein the first polypeptide fragment has at least 98% sequence identity to amino acids 19 to 455 of SEQ ID NO: 2.

5. The hybrid polypeptide of claim 1 , wherein the first polypeptide fragment has at least 99% sequence identity to amino acids 19 to 455 of SEQ ID NO: 2.

6. The hybrid polypeptide of claim 1 , wherein the first polypeptide fragment comprises amino acids 19 to 455 of SEQ ID NO: 2.

7. The hybrid polypeptide of claim 1 , wherein the first polypeptide fragment consists of amino acids 19 to 455 of SEQ ID NO: 2.

8. The hybrid polypeptide of claim 1 , wherein the second polypeptide fragment has at least 96% sequence identity to amino acids 468 to 532 of SEQ ID NO: 4.

9. The hybrid polypeptide of claim 1 , wherein the second polypeptide fragment has at least 97% sequence identity to amino acids 468 to 532 of SEQ ID NO: 4.

10. The hybrid polypeptide of claim 1 , wherein the second polypeptide fragment has at least 98% sequence identity to amino acids 468 to 532 of SEQ ID NO: 4.

11. The hybrid polypeptide of claim 1 , wherein the second polypeptide fragment has at least 99% sequence identity to amino acids 468 to 532 of SEQ ID NO: 4.

12. The hybrid polypeptide of claim 1 , wherein the second polypeptide fragment comprises amino acids 468 to 532 of SEQ ID NO: 4.

13. The hybrid polypeptide of claim 1 , wherein the second polypeptide fragment consists of amino acids 468 to 532 of SEQ ID NO: 4.

14. The hybrid polypeptide of claim 7 , wherein the second polypeptide fragment consists of amino acids 468 to 532 of SEQ ID NO: 4.

15. A polynucleotide encoding the hybrid polypeptide of claim 1 .

16. A host cell comprising the polynucleotide of claim 15 , wherein the polynucleotide is operably linked to control sequences that provide for the expression of the hybrid polypeptide by the host cell.

17. A method of producing a hybrid polypeptide having cellobiohydrolase activity, comprising:

(a) cultivating the host cell of claim 16 under conditions suitable for the expression of the hybrid polypeptide; and

(b) recovering the hybrid polypeptide.

18. A process for degrading or converting a cellulosic material, comprising: treating the cellulosic material with a hybrid polypeptide of claim 1 , an endoglucanase, a beta-glucosidase, and a GH61 polypeptide.

19. The process of claim 18 , wherein the cellulosic material is pretreated.

20. The process of claim 18 , further comprising recovering the degraded cellulosic material.

21. The process of claim 20 , wherein the degraded cellulosic material is a sugar.

22. The process of claim 21 , wherein the sugar is selected from the group consisting of arabinose, galactose, glucose, mannose, and xylose.

23. A process for producing a fermentation product, comprising:

(a) saccharifying a cellulosic material with a hybrid polypeptide of claim 1 , an endoglucanase, a beta-glucosidase, and a GH61 polypeptide;

(b) fermenting the saccharified cellulosic material with one or more fermenting microorganisms to produce the fermentation product; and

(c) recovering the fermentation product.

24. The process of claim 23 , wherein the cellulosic material is pretreated.

25. The process of claim 23 , wherein steps (a) and (b) are performed simultaneously in a simultaneous saccharification and fermentation.

26. The process of claim 23 , wherein the fermentation product is an alcohol, an alkane, a cycloalkane, an alkene, an amino acid, a gas, isoprene, a ketone, an organic acid, or polyketide.

Assignments (1)
CONFIRMATORY LICENSE Recorded Sep 3, 2019
From: NOVOZYMES, INC.
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 051890/0379 →
Priority Claims (1)
WO PCT/CN2011/084419 · Dec 22, 2011 · international
Continuity (2)
Provisional Application 61586540 · Jan 13, 2012
Related Publication 20140377827A1 · Dec 25, 2014